The role of Genomics Innovation at Sanger: Our Case Studies and Role Models

Our case studies and role models show the journeys of very different scientitsts and the technologies they have developed. From our very first spin-out (Kymab), to accidental entrepreneurs, problem-solvers, all the way through to the stories of three scientific teams working on Malaria.

For Industry

We seek to partner with organisations that can help us deliver on our translation agenda. We work flexibly with industry and investors to apply our research to solve real world challenges. We use a range of mechanisms including R&D collaboration, licensing, or spinning out.

Find out more

For Scientists

We enable our scientists to explore entrepreneurship via training and targeted events. The team’s expertise in business development enables our scientists to build on/extend the reach of their research into a product or service with the aim of creating societal benefit.

Find out more
Spin-Outs

Spin-outs

We’ve supported the creation of innovative Genomics and Biodata Sanger spin-out companies stemming from Sanger research. Learn more about Congenica, Kymab, Microbiotica and Mosaic. 

Find out more

Licenses

Licences

Licensing is one way we disseminate knowledge and resources to benefit the scientific community and improve healthcare

Find out more

Collaborations

Partnerships

Strategic partnerships marry the formidable science base of the Institute with the capabilities of commercial partners to add value to our technologies.

Find out more

Sanger Technologies

Applying our science to benefit society by empowering innovators and engaging with businesses and investors. 

Wellcome Sanger Institute